UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)
Clinical trials for UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS) explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS) trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beams take aim at inoperable sarcomas in new trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. Researchers will also look at bl…
Matched conditions: UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called OKN4395, alone or with an immunotherapy (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and see if the drug can shrink tumors. About 166…
Matched conditions: UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)
Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether a personalized, 3-week course of proton or x-ray radiation before surgery can reduce long-term side effects for adults with soft tissue sarcoma. About 110 participants will have two radiation plans made, and a national team will choose the best one for ea…
Matched conditions: UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 08, 2026 12:04 UTC